ā¢
Sep 30, 2022
Sight Sciences Q3 2022 Earnings Report
Reported financial results for the third quarter ended September 30, 2022.
Key Takeaways
Sight Sciences reported a 43% increase in revenue compared to the third quarter of 2021, with Surgical Glaucoma revenue increasing by 37% and Dry Eye revenue increasing by 145%. The company achieved a gross margin of 84%.
Total revenue of $18.7 million, an increase of 43% compared to the prior year period.
Gross margin of 84%.
Increased the number of facilities ordering the OMNIĀ® Surgical System to 913.
Launched the SIONā¢ Surgical Instrument.
Sight Sciences
Sight Sciences
Sight Sciences Revenue by Segment
Forward Guidance
Sight Sciences now projects revenue for the full year 2022 to range from $70 million to $72 million, which represents growth of approximately 43% to 47% compared to 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income